Low-dose aspirin does not affect the progression of age-related hearing loss

FHS
July 30, 2024
9:24 am

The effect of daily low-dose aspirin versus placebo on the progression of age-related hearing loss in healthy older adults.

HRSA pushes back against another 340B rebate model, this time from Sanofi

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 17, 2024

Bipartisan ‘pill penalty’ fix and other bills vie for inclusion in reconciliation package

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

March 1, 2025

Trying to outrun her prion disease, researcher creates powerful epigenetic editor in mice

Sonia Vallabh always thought genome editing wouldn’t be an option. It was such an obvious solution that people invariably asked, “What about CRISPR?” at the

June 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.